All In MedTech

Device Trial Radar · NCT07950163

Paired Associative Stimulation of the Motor Cortex and the Dorsal Roots of the Cervical Spine for the Recovery of Arm and Hand Function in Chronic Middle Cerebral Artery Stroke. ASCLEPIUS Safety Evaluation Pilot Study

Paired Associative Stimulation of the Motor Cortex and the Dorsal Roots of the Cervical Spine for the Recovery of Arm and Hand Function in Chronic Middle Cerebral Artery Stroke. ASCLEPIUS Safety Evaluation Pilot Study (Epidural Associative Stimulation of the Cerebral Cortex and Spinal Cord to Increase Plasticity in Upper Limb Stroke)

Last checked: Nov 20, 2026Latest source record: Nov 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

12

Planned (sponsor's estimate)

Start

Dec 2026

Primary completion

Dec 2029

Study completion Dec 2029

Sponsor

Lead sponsor
Juan Antonio Barcia AlbacarAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Boston Scientific Corporation
First posted
Nov 20, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Double (participant, outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 84 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this pilot clinical trial is to learn whether paired associative stimulation (PAS) of the primary motor cortex and the cervical spinal dorsal roots, delivered through implanted epidural electrodes and combined with neurorehabilitation, is safe in adults with chronic paresis or paralysis of the arm and hand after a stroke in the territory of the middle cerebral artery. The main question it aims to answer is: \* What adverse events occur during 12 months of follow-up with this treatment? Secondary questions are whether the stimulation is feasible (whether pairing the corresponding electrode contacts of the motor cortex and the cervical spinal cord increases the motor response to stimulation) and whether it shows preliminary signs of efficacy on upper limb motor function, quality of life and caregiver burden. Researchers will compare PAS plus rehabilitation with sham stimulation plus rehabilitation during a two-month double-blind phase. Participants will: * Have epidural electrodes surgically implanted over the primary motor cortex and the cervical spinal cord, connected to an implanted pulse generator * Receive PAS or sham stimulation together with rehabilitation sessions for two months * If assigned to sham stimulation, receive open-label PAS plus rehabilitation for a further two months * Attend follow-up visits for 12 months

Conditions

  • Stroke
  • Infarction, Middle Cerebral Artery
  • Hemiparesis
  • Upper Extremity Paresis

Interventions

  • Epidural paired associative stimulation of the motor cortex and cervical dorsal rootsDevice

    Paired associative stimulation (PAS) delivered through an implanted 32-contact pulse generator (WaveWriter Alpha, Boston Scientific) connected to an epidural lead over the primary motor cortex (Artisan MRI Surgical Lead) and two epidural leads over the cervical spinal cord, C3 to T1, placed laterally towards the dorsal roots of the affected side (Linear Lead). Cortical and cervical contacts that evoke responses in the same muscle group are paired, with an inter-stimulus delay derived from the EMG response latencies of each contact. Stimulus intensity is set immediately below the threshold for a motor response. Stimulation is applied during rehabilitation sessions and adjusted weekly for two months. The devices are CE-marked and used outside their intended purpose.

  • Sham epidural stimulationDevice

    Same implanted system as in the experimental arm. The pulse generator is programmed with settings that are not effective for inducing paired associative stimulation: stimulation of a single contact of the spinal lead with settings that produce paresthesia but no motor response. Sham stimulation is applied during rehabilitation sessions and reviewed weekly for two months, with the same visit schedule as the experimental arm.

  • NeurorehabilitationOther

    Multidisciplinary neurorehabilitation program for the affected upper limb combining physiotherapy and occupational therapy, delivered two or three days per week on alternate days according to clinical status and tolerance, during the stimulation phases. The program is identical in both arms and is delivered by rehabilitation staff blinded to group allocation during Phase I.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Cumulative incidence of adverse eventsTime frame: From surgery to 12 months after hospital discharge

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Hospital Clínico San Carlos

    Madrid, Spain

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.